296 related articles for article (PubMed ID: 29218233)
1. Targeted Delivery of siRNA Therapeutics to Malignant Tumors.
Leng Q; Woodle MC; Mixson AJ
J Drug Deliv; 2017; 2017():6971297. PubMed ID: 29218233
[TBL] [Abstract][Full Text] [Related]
2. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
3. Ligand-targeted theranostic nanomedicines against cancer.
Yao VJ; D'Angelo S; Butler KS; Theron C; Smith TL; Marchiò S; Gelovani JG; Sidman RL; Dobroff AS; Brinker CJ; Bradbury ARM; Arap W; Pasqualini R
J Control Release; 2016 Oct; 240():267-286. PubMed ID: 26772878
[TBL] [Abstract][Full Text] [Related]
4. Advances in phage display technology for drug discovery.
Omidfar K; Daneshpour M
Expert Opin Drug Discov; 2015 Jun; 10(6):651-69. PubMed ID: 25910798
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
6. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
7. Optimization of siRNA delivery to target sites: issues and future directions.
Khalil IA; Yamada Y; Harashima H
Expert Opin Drug Deliv; 2018 Nov; 15(11):1053-1065. PubMed ID: 30198792
[TBL] [Abstract][Full Text] [Related]
8. What are the key targeted delivery technologies of siRNA now?
Sioud M
Methods Mol Biol; 2010; 629():93-107. PubMed ID: 20387145
[TBL] [Abstract][Full Text] [Related]
9. Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems.
Yoo J; Park C; Yi G; Lee D; Koo H
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31072061
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in oligonucleotide therapeutics: antisense to aptamers.
Leaman DW
Expert Opin Drug Discov; 2008 Sep; 3(9):997-1009. PubMed ID: 23506176
[TBL] [Abstract][Full Text] [Related]
11. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
Sivakumar P; Kim S; Kang HC; Shim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
[TBL] [Abstract][Full Text] [Related]
12. In vivo application of RNA interference: from functional genomics to therapeutics.
Lu PY; Xie F; Woodle MC
Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
[TBL] [Abstract][Full Text] [Related]
13. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.
Lorenzer C; Dirin M; Winkler AM; Baumann V; Winkler J
J Control Release; 2015 Apr; 203():1-15. PubMed ID: 25660205
[TBL] [Abstract][Full Text] [Related]
14. Recognition Sites for Cancer-targeting Drug Delivery Systems.
Guan S; Zhang Q; Bao J; Hu R; Czech T; Tang J
Curr Drug Metab; 2019; 20(10):815-834. PubMed ID: 31580248
[TBL] [Abstract][Full Text] [Related]
15. Vascular targeting: recent advances and therapeutic perspectives.
Hajitou A; Pasqualini R; Arap W
Trends Cardiovasc Med; 2006 Apr; 16(3):80-8. PubMed ID: 16546688
[TBL] [Abstract][Full Text] [Related]
16. A Poly(Propyleneimine) Dendrimer-Based Polyplex-System for Single-Chain Antibody-Mediated Targeted Delivery and Cellular Uptake of SiRNA.
Tietze S; Schau I; Michen S; Ennen F; Janke A; Schackert G; Aigner A; Appelhans D; Temme A
Small; 2017 Jul; 13(27):. PubMed ID: 28544767
[TBL] [Abstract][Full Text] [Related]
17. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
[TBL] [Abstract][Full Text] [Related]
18. Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics.
Sioud M
Mol Biotechnol; 2019 Apr; 61(4):286-303. PubMed ID: 30729435
[TBL] [Abstract][Full Text] [Related]
19. Aptamer-iRNAs as Therapeutics for Cancer Treatment.
Soldevilla MM; Meraviglia-Crivelli de Caso D; Menon AP; Pastor F
Pharmaceuticals (Basel); 2018 Oct; 11(4):. PubMed ID: 30340426
[TBL] [Abstract][Full Text] [Related]
20. Ligand-targeted delivery of therapeutic siRNA.
Ikeda Y; Taira K
Pharm Res; 2006 Aug; 23(8):1631-40. PubMed ID: 16850274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
